These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7021793)

  • 1. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease.
    Manouchehr-Pour M; Spagnuolo PJ; Rodman HM; Bissada NF
    J Periodontol; 1981 Aug; 52(8):410-5. PubMed ID: 7021793
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.
    Palmblad J; Udén AM; Friberg I; Ringertz B; Rådmark O; Lindgren JA; Hansson G; Malmsten CL
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():25-31. PubMed ID: 6303087
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

  • 4. A possible role for cold insoluble globulin in chemotactic factor mediated polymorphonuclear leukocyte adherence to plastic.
    Spagnuolo PJ; Lederman MM; Schiltz J; Ellner J; Culp L
    Biochem Biophys Res Commun; 1982 May; 106(2):471-8. PubMed ID: 7049175
    [No Abstract]   [Full Text] [Related]  

  • 5. The alterative effect of isobutylmethylxanthine in hypofunctional human neutrophil chemotaxis.
    Debski BF; Ranney RR; Carchman RA
    Biochem Biophys Res Commun; 1982 Oct; 108(3):1228-34. PubMed ID: 6185116
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of granulocyte response to the chemoattractant F-Met-Leu-Phe.
    Dahlgren C; Stendahl O
    Adv Exp Med Biol; 1982; 155():107-12. PubMed ID: 6297266
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotactic stimuli-induced changes in the pHi of rabbit neutrophils.
    Sha'afi RI; Naccache PH; Molski TF; Volpi M
    Kroc Found Ser; 1981; 15():513-25. PubMed ID: 6951955
    [No Abstract]   [Full Text] [Related]  

  • 9. Phloretin is a potent inhibitor of rabbit neutrophil activation by chemotactic factors.
    Shefcyk J; Molski TF; Volpi M; Naccache PH; Sha'afi RI
    Biochim Biophys Acta; 1983 Feb; 728(1):97-102. PubMed ID: 6830775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
    Dahinden C; Fehr J
    J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
    O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration of calcium-dependent chemotactic factor activatable esterase activity in human neutrophils: relationship with chemotaxis and chemotactic deactivation.
    Mehta J; Mandell B; Kleyman T; Spilberg I
    Inflammation; 1981 Jun; 5(2):89-101. PubMed ID: 7275278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo crevicular leukocyte response to a chemotactic challenge: inhibition by experimental diabetes.
    Golub LM; Nicoll GA; Iacono VJ; Ramamurthy NS
    Infect Immun; 1982 Sep; 37(3):1013-20. PubMed ID: 6752017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.
    Fearon DT; Collins LA
    J Immunol; 1983 Jan; 130(1):370-5. PubMed ID: 6847888
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides.
    English D; Roloff JS; Lukens JN
    J Immunol; 1981 Jan; 126(1):165-71. PubMed ID: 6256437
    [No Abstract]   [Full Text] [Related]  

  • 16. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-reactive stimuli selectively increase protein phosphorylation in human neutrophils.
    Schneider C; Zanetti M; Romeo D
    FEBS Lett; 1981 May; 127(1):4-8. PubMed ID: 7250373
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG; Brown PD
    Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin polymerization induced by chemotactic peptide and concanavalin A in rat neutrophils.
    Rao KM; Varani J
    J Immunol; 1982 Oct; 129(4):1605-7. PubMed ID: 6286771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.